Prophylaxis Against Dialysis Catheter-Related Bacteremia: A Glimmer of Hope

American Journal of Kidney Diseases

Volumn 51, Issue 2, 2008, Pages 165-168

  Allon, Michael ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFOTAXIME; CITRIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; TAUROLIDINE;

BACTEREMIA; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIALYSIS CATHETER; DISEASE COURSE; ECONOMIC ASPECT; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH SERVICE; HEMODIALYSIS; HOPE; HOSPITALIZATION; HUMAN; HYPOCALCEMIA; LABORATORY TEST; METASTASIS; MORBIDITY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS EPIDERMIDIS;

AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG RESISTANCE, BACTERIAL; HEMODIAFILTRATION; HOSPITALIZATION; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REIMBURSEMENT MECHANISMS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; UNITED STATES;

EID: 38149057228     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.12.003     Document Type: Editorial

References (17)

1. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 44 (2004) 779-791
2. Lee T., Barker J., and Allon M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am J Kidney Dis 46 (2005) 501-508
3. Centers for Medicare and Medicaid Services. 2004 annual report: End-stage renal disease clinical performance measures project. Am J Kidney Dis 46 (2005) 1-100
4. Donlan R.M. Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33 (2001) 1387-1392
5. Shah C.B., Mittelman M.W., Costerton J.W., et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob Agents Chemother 46 (2002) 1674-1679
6. Weijmer M.C., Debets-Ossenkopp Y.J., van der Vondervoort F.J., et al. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant 17 (2002) 2189-2195
7. Jaffer Y., Selby N.M., Taal M.W., et al. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 51 (2008) 233-241
8. Dogra G.K., Herson H., Hutchison B., et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13 (2002) 2133-2139
9. Kim S.H., Song K.I., Chang J.W., et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective randomized clinical trial. Kidney Int 69 (2006) 161-164
10. McIntyre C.W., Hulme L.J., Taal M., et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66 (2004) 801-805
11. Nori U.S., Manoharan A., Yee J., et al. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48 (2006) 596-605
12. Saxena A.K., Panhotra B.R., Sundaram D.S., et al. Enhancing the survival of tunneled hemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton) 11 (2006) 299-305
13. Betjes M.G.H., and van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19 (2004) 1546-1551
14. Weijmer M.C., Van den Dorpel A., Van de Ven P.J.G., et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16 (2005) 2769-2777
15. Guerraoui A.A., Dacosta E.E., Roche B.B., et al. Emergence of multiresistant Staphylococcus epidermidis (MRSE) after lock antibiotic regimen by gentamicin in permanent hemodialysis catheters. Prospective study, 1999-2003. J Am Soc Nephrol 15 (2004) 368A (abstr)
16. Food and Drug Administration. FDA Talk Paper: FDA Issues Warning on Tricitrasol Dialysis Catheter Anticoagulant. http://www.fda.gov/bbs/topics/answers/ANS01009.html Accessed November 21, 2007
17. Reaven N.L. Cost of hemodialysis catheter-related complications. J Am Soc Nephrol 14 (2003) 243A (abstr)